Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The nicotinamide adenine dinucleotide (NAD) pathway refers to the series of biochemical reactions responsible for the synthesis, utilization, and recycling of NAD⁺ and its reduced form NADH. NAD⁺ is a vital coenzyme found in all living cells, playing central roles in metabolism, energy production, DNA repair, gene expression regulation, and cell signaling. Restoring or boosting cellular NAD levels—via supplementation with precursors like NR (nicotinamide riboside), NMN (nicotinamide mononucleotide), niacinamide/nicotinic acid—has been investigated for potential benefits against aging-related conditions and metabolic disorders.
Boosting NAD+ levels via supplementation with precursors
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nicotinamide Adenine Dinucleotide Pathway (None).